Have a
regulatory affairs
challenge?
Pharma and Biotech Latest Insights
Curated Regulatory Intelligence Augmented by AI
Pharma and Biotech
Thailand Published the Criteria, Methods and Conditions of Drug Research St…
The Thailand Ministry of Public Health published the benefits of promoting, supporting, and developing effective...
Read more
Pharma and Biotech
TGA Introduced Changes Applying to Evaluation of New Substances for Listed …
The TGA has introduced changes regarding the evaluation of new ingredients to be used in...
Read more
Pharma and Biotech
Taiwan FDA published Guidelines for the Implementation of Drug Epidemiologi…
Real-world evidence is the latest international clinical application trend, which can be used to improve...
Read more
Pharma and Biotech
Thai FDA Issued Criteria, Methods and Conditions for Sampling of Herbal Pro…
The Thai Food and Drug Administration (TFDA) Issued Criteria, methods, and conditions for the sampling...
Read more
Pharma and Biotech
EU Recommendations to Facilitate the Conduct of Decentralized Clinical Tria…
The European Commission (EC), the Heads of Medicines Agencies (HMA), and the European Medicines Agency...
Read more
Pharma and Biotech
Thailand Issued a Draft Notification on the Names of Substances Prohibited …
There are 3 lists of substances (plants, animals or parts of plants or animals), prohibited...
Read more
Pharma and Biotech
EU: Amendment to the Clinical Trials Regulation (CTR) on Investigational Me…
The European Commission (EC) revised the current labelling requirements provided in the Clinical Trials Regulation...
Read more
Pharma and Biotech
Thailand Issues the Notification Declaring the Inflorescence of Cannabis as…
This new Notification Re: Controlled Herb (Cannabis) B. E. 2565 (2022) dated 11th Nov 2022...
Read more
Pharma and Biotech
TGA – Standard for Serialization and Data Matrix Codes for Medicines …
The Therapeutic Goods (Medicines – Standard for Serialisation and Data Matrix Codes) (TGO 106) Order...
Read more
Pharma and Biotech
India Proposed Amendment to New Drugs and Clinical Trials Rules
The India Ministry of Health and Family Welfare (MoHFW) proposed an amendment to New Drugs...
Read more